GO
Loading...

Johnson & Johnson

More

  • July 11- Big Pharma companies are trying to offload low-growth, mature drug portfolios to firms such as Blackstone Group LP and TPG Capital LP which need to figure out how to carve them out, in one of private equity's greatest dealmaking challenges.

  • Business events scheduled for the coming week Friday, 11 Jul 2014 | 2:10 PM ET

    WASHINGTON— Commerce Department releases retail sales data for June, 8:30 a.m.; Commerce Department releases business inventories for May, 10 a.m.. BERLIN— Germany's ZEW institute releases its monthly index of investor confidence in Europe's biggest economy.

  • Midday Glance: Medical Devices companies Friday, 11 Jul 2014 | 1:37 PM ET

    Allergan rose$. 08 or percent, to $165.68. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 07 or. 5 percent, to $13.03.

  • Midday Glance: Pharmaceuticals companies Friday, 11 Jul 2014 | 1:37 PM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Bristol-Myers Squibb Co. fell$. 07 or. 1 percent, to $48.44. Hospira fell$. 34 or. 7 percent, to $50.72.

  • The Alzheimer's epidemic: Where we stand Friday, 11 Jul 2014 | 11:45 AM ET

    Although treatments for Alzheimer's have struggled, drugmakers are still working in the space, with 67 medicines currently in development.

  • Early Glance: Medical Devices companies Friday, 11 Jul 2014 | 10:30 AM ET

    Allergan fell$. 62 or. 4 percent, to $164.98. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $12.95.

  • Early Glance: Pharmaceuticals companies Friday, 11 Jul 2014 | 10:30 AM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $48.40. Hospira fell$. 22 or. 4 percent, to $50.84.

  • For the larger companies, the initiative ensures that their own suppliers are robust and "demonstrates a recognition that a healthy supply chain is good for business," the White House said in a statement.

  • Midday Glance: Pharmaceuticals companies Thursday, 10 Jul 2014 | 1:44 PM ET

    Baxter International Inc. rose$. 65 or. 9 percent, to $76.47. Bristol-Myers Squibb Co. rose$. 58 or 1.2 percent, to $48.50. Hospira fell$. 56 or 1.1 percent, to $50.95.

  • Midday Glance: Medical Devices companies Thursday, 10 Jul 2014 | 1:44 PM ET

    Allergan fell $1.06 or. 6 percent, to $164.14. Baxter International Inc. rose$. 65 or. 9 percent, to $76.47. Boston Scientific Corp. fell$. 01 or. 1 percent, to $13.01.

  • Early Glance: Medical Devices companies Thursday, 10 Jul 2014 | 11:01 AM ET

    Allergan fell $1.32 or. 8 percent, to $163.88. Baxter International Inc. fell$. 10 or. 1 percent, to $75.72. Boston Scientific Corp. fell$. 13 or 1.0 percent, to $12.89.

  • Early Glance: Pharmaceuticals companies Thursday, 10 Jul 2014 | 11:01 AM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $75.72. Bristol-Myers Squibb Co. fell$. 09 or. 2 percent, to $47.83. Hospira fell$. 71 or 1.4 percent, to $50.80.

  • High-tech way to apply sunscreen Wednesday, 9 Jul 2014 | 3:32 PM ET
    SnappyScreen applies sunscreen over entire body in 10 seconds

    SnappyScreen founder Kristen McClellan says she has a better, faster way to apply sunscreen. Will the Power Pitch panel agree?

  • *France's Servier, Israel's Teva among those fined. BRUSSELS, July 9- European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others a total of 428 million euros on Wednesday, as they crack down on deals which block cheaper generic medicine.

  • *Sodexo cuts 2013/ 14 sales growth goal to 2.2-2.5 pct. *Sodexo keeps full-year profit goals. PARIS, July 9- Sodexo, the world's second-biggest catering services company, cut it full-year sales growth forecast on Wednesday, warning its fourth quarter would be weaker than expected due to the delayed start-up of some large contracts.

  • In preparatory documents posted on the agency's website on Tuesday, FDA reviewers said laparoscopic power morcellator devices, which are used to treat uterine fibroids, allow for less invasive surgeries, shorter recovery time and fewer wound site infections.

  • LONDON, July 6- The drugs don't work- and neither does the market, when it comes to antibiotics. Totally resistant forms of the lung infection emerged in India just a few years ago and have now been detected worldwide.

  • INSIGHT-How to fix a broken market in antibiotics Sunday, 6 Jul 2014 | 4:59 AM ET

    LONDON, July 6- The drugs don't work- and neither does the market, when it comes to antibiotics. Totally resistant forms of the lung infection emerged in India just a few years ago and have now been detected worldwide.

  • Laggardly Dow crosses 17,000 milestone Thursday, 3 Jul 2014 | 12:09 PM ET

    NEW YORK, July 3- Wall Street on Thursday celebrated its love of zeros- the ones that come after commas, that is- as the Dow Jones Industrial Average topped the 17,000 mark for the first time.

  • *Roche adds to breast cancer drug offering with Seragon. Roche is looking to bolster its offering of breast cancer drugs with the purchase. Since walking away from a $6.8 billion deal to buy U.S gene sequencing company Illumina in 2012 Roche has eschewed multi-billion deals and instead snapped up a couple of smaller diagnostic companies so far this year.